Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Porphyromycin
2. Mls000766209
3. Mitomycin C, N-methyl-
4. Methylmitomycin
5. Chembl1983333
6. Methyl Mitomycin C
7. Nsc56410
8. Regamycin
9. Ent-50825
10. Nsc 56410
11. Profiromycin
12. Neuro_000023
13. Schembl5047
14. Chebi:182803
15. Hms2270b05
16. Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-1,5-dimethyl-, Carbamate (ester)
17. Bdbm50235885
18. Akos030254763
19. Ncgc00246835-01
20. Nci60_004377
21. Smr000528838
22. U 14743
23. Ft-0673976
24. Wln: T D3 B556 Bn En Jv Mvttt&j E1 Go1 H1ovz Kz L1
25. (11-amino-7-methoxy-5,12-dimethyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl)methyl Carbamate
26. (6-amino-8a-methoxy-1,5-dimethyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazireno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl)methyl Carbamate
27. (6-amino-8a-methoxy-1,5-dimethyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazireno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl)methyl Carbamate #
28. 1-methyl-6-amino-8a-methoxy-8-[(carbamoyloxy)methyl]-5-methyl-1,1a,2,8,8a,8b-hexahydroazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione
29. 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-1,5-dimethylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dionecarbamate (ester)
30. Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-1,5-dimethyl-, Carbamate
31. Azirino[2',3':3,4]pyrrolo[1,2-a]-indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-1,5-dimethyl-, (1as,8s,8ar,8bs)-
32. Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-1,5-dimethyl-, [1as-(1a.alpha.,8.beta.,8a.alpha.,8b.alpha.)]-
33. Azirino[2',4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a- Methoxy-1,5-dimethyl-, Carbamate (ester)
34. Azirino[2',4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b- Hexahydro-8a-methoxy-1,5-dimethyl-,[1ar-(1a.alpha.,8.beta.,8a.alpha.,8b.alpha.)]-
| Molecular Weight | 348.35 g/mol |
|---|---|
| Molecular Formula | C16H20N4O5 |
| XLogP3 | -0.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 348.14336975 g/mol |
| Monoisotopic Mass | 348.14336975 g/mol |
| Topological Polar Surface Area | 128 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 787 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 4 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Porfiromycin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Porfiromycin, including repackagers and relabelers. The FDA regulates Porfiromycin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Porfiromycin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Porfiromycin supplier is an individual or a company that provides Porfiromycin active pharmaceutical ingredient (API) or Porfiromycin finished formulations upon request. The Porfiromycin suppliers may include Porfiromycin API manufacturers, exporters, distributors and traders.
click here to find a list of Porfiromycin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Porfiromycin DMF (Drug Master File) is a document detailing the whole manufacturing process of Porfiromycin active pharmaceutical ingredient (API) in detail. Different forms of Porfiromycin DMFs exist exist since differing nations have different regulations, such as Porfiromycin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Porfiromycin DMF submitted to regulatory agencies in the US is known as a USDMF. Porfiromycin USDMF includes data on Porfiromycin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Porfiromycin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Porfiromycin suppliers with USDMF on PharmaCompass.
Porfiromycin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Porfiromycin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Porfiromycin GMP manufacturer or Porfiromycin GMP API supplier for your needs.
A Porfiromycin CoA (Certificate of Analysis) is a formal document that attests to Porfiromycin's compliance with Porfiromycin specifications and serves as a tool for batch-level quality control.
Porfiromycin CoA mostly includes findings from lab analyses of a specific batch. For each Porfiromycin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Porfiromycin may be tested according to a variety of international standards, such as European Pharmacopoeia (Porfiromycin EP), Porfiromycin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Porfiromycin USP).
LOOKING FOR A SUPPLIER?
